Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Phase I clinical and pharmacokinetic study of 3-weekly, 3-h infusion of ixabepilone (BMS-247550), an epothilone B analog, in Japanese patients with refractory solid tumors. | Cancer Chemother Pharmacol | 2007 | 0.86 |